S100A8/S100A9
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1
20
Autoinhibitory regulation of S100A8/S100A9 alarmin activity locally restricts sterile inflammation
16
S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism
12
S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV 1 replication by NK cells
11
Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes
11
Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent onset rheumatoid arthritis
9
S100A8/A9 increases the mobilization of pro inflammatory Ly6Chigh monocytes to the synovium during experimental osteoarthritis
15
S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis
12
Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products
9
S100A8 and S100A9 in experimental osteoarthritis
13
Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulator
11
Fcγ receptor mediated influx of S100A8/A9 producing neutrophils as inducer of bone erosion during antigen induced arthritis
15
S100A8 inhibits PDGF-induced proliferation of airway smooth muscle cells dependent on the receptor for advanced glycation end-products
8
Visualization of Tumor-Immune Interaction - Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment
10
Visualization of Tumor-Immune Interaction - Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment.
29
High expression of <em>S100A8</em> gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway
13
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
10
Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti TNF treatment in patients with rheumatoid arthritis
7
Calprotectin (S100A8/A9) has the strongest association with ultrasound detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis
10
The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen activated protein kinase in rheumatoid arthritis
12